Prevalence and Incidence of Dry Eye and Meibomian Gland Dysfunction in the United States A Systematic Review and Meta-analysis

被引:40
|
作者
McCann, Paul [1 ]
Abraham, Alison G. [1 ,2 ]
Mukhopadhyay, Adhuna [2 ]
Panagiotopoulou, Kanella [3 ]
Chen, Hongan [1 ]
Rittiphairoj, Thanitsara [1 ]
Gregory, Darren G. [1 ]
Hauswirth, Scott G. [1 ]
Ifantides, Cristos [1 ]
Qureshi, Riaz [1 ,2 ]
Liu, Su-Hsun [1 ,2 ]
Saldanha, Ian J. [4 ,5 ]
Li, Tianjing [1 ,2 ]
机构
[1] Univ Colorado Anschutz Med Campus, Dept Ophthalmol, Aurora, CO USA
[2] Colorado Sch Publ Hlth, Dept Epidemiol, Aurora, CO USA
[3] Univ Paris Cite, Res Ctr Epidemiol & Stat CRESS U1153, INSERM, Paris, France
[4] Brown Univ, Sch Publ Hlth, Dept Hlth Serv Policy & Practice, Ctr Evidence Synth Hlth, Providence, RI USA
[5] Brown Univ, Sch Publ Hlth, Dept Epidemiol, Providence, RI USA
基金
美国国家卫生研究院;
关键词
RISK-FACTORS; INTERNATIONAL WORKSHOP; DISEASE; CLASSIFICATION; EPIDEMIOLOGY; DEFINITION;
D O I
10.1001/jamaophthalmol.2022.4394
中图分类号
R77 [眼科学];
学科分类号
100212 ;
摘要
IMPORTANCE Dry eye is a common clinical manifestation, a leading cause of eye clinic visits, and a significant societal and personal economic burden in the United States. Meibomian gland dysfunction (MGD) is a major cause of evaporative dry eye. OBJECTIVE To conduct a systematic review and meta-analysis to obtain updated estimates of the prevalence and incidence of dry eye and MGD in the United States. DATA SOURCES Ovid MEDLINE and Embase. STUDY SELECTION A search conducted on August 16, 2021, identified studies published between January 1, 2010, and August 16, 2021, with no restrictions regarding participant age or language of publication. Case reports, case series, case-control studies, and interventional studies were excluded. DATA EXTRACTION AND SYNTHESIS The conduct of review followed a protocol registered on PROSPERO (CRD42021256934). PRISMA guidelines were followed for reporting. Joanna Briggs Institute and Newcastle Ottawa Scale tools were used to assess risk of bias. Data extraction was conducted by 1 reviewer and verified by another for accuracy. Prevalence of dry eye and MGD were combined in separate meta-analyses using random-effects models. MAIN OUTCOMES AND MEASURES Prevalence and incidence of dry eye and MGD in the United States. Summary estimates from meta-analysis of dry eye and MGD prevalence with 95% CI and 95% prediction intervals (95% PI). RESULTS Thirteen studies were included in the systematic review. Dry eye prevalence was reported by 10 studies, dry eye incidence by 2 studies, and MGD prevalence by 3 studies. Meta-analysis estimated a dry eye prevalence of 8.1% (95% CI, 4.9%131%; 95% PI, 0%-98.9%; 3 studies; 9 808 758 participants) and MGD prevalence of 21.2% (95% CI, 7.2%-48.3%; 95% PI, 0%-100%; 3 studies; 19 648 participants). Dry eye incidence was 3.5% in a population 18 years and older and 7.8% in a population aged 68 years and older. No studies reported MGD incidence. CONCLUSIONS AND RELEVANCE This systematic review and meta-analysis demonstrated uncertainty about the prevalence and incidence of dry eye and MGD in the United States. Population-based epidemiological studies that use consistent and validated definitions of dry eye and MGD are needed for higher-certainty estimates of dry eye and MGD prevalence and incidence in the United States.
引用
收藏
页码:1181 / 1192
页数:12
相关论文
共 50 条
  • [1] Prevalence of dry eye and Meibomian gland dysfunction in Central and South America: a systematic review and meta-analysis
    Chen, Hongan
    Mccann, Paul
    Lien, Tiffany
    Xiao, Mengli
    Abraham, Alison G.
    Gregory, Darren G.
    Hauswirth, Scott G.
    Qureshi, Riaz
    Liu, Su-Hsun
    Saldanha, Ian J.
    Li, Tianjing
    [J]. BMC OPHTHALMOLOGY, 2024, 24 (01)
  • [2] Prevalence of dry eye and Meibomian gland dysfunction in Central and South America: a systematic review and meta-analysis
    Hongan Chen
    Paul McCann
    Tiffany Lien
    Mengli Xiao
    Alison G. Abraham
    Darren G. Gregory
    Scott G. Hauswirth
    Riaz Qureshi
    Su-Hsun Liu
    Ian J. Saldanha
    Tianjing Li
    [J]. BMC Ophthalmology, 24
  • [3] Global Prevalence of Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
    Hassanzadeh, Samira
    Varmaghani, Mehdi
    Zarei-Ghanavati, Siamak
    Heravian Shandiz, Javad
    Azimi Khorasani, Abbas
    [J]. OCULAR IMMUNOLOGY AND INFLAMMATION, 2021, 29 (01) : 66 - 75
  • [4] Meibomian gland dysfunction and primary Sjogren's syndrome dry eye: a protocol for systematic review and meta-analysis
    Zi, Changyan
    Huang, Qun
    Ren, Yuan
    Yao, Huan
    He, Tingting
    Gao, Yongxiang
    [J]. BMJ OPEN, 2021, 11 (12):
  • [5] PREVALENCE OF MEIBOMIAN GLAND DYSFUNCTION IN AFRICA: A SYSTEMATIC REVIEW AND META-ANALYSIS OF OBSERVATIONAL STUDIES
    Akowuah, Prince Kwaku
    Kobia-Acquah, Emmanuel
    Donkor, Richard
    Arthur, Christabel
    Senanu, Esther Nutifafa
    Dadzie, Emmanuela Esi
    Frimpong, Asafo Agyei
    Otabil, Fredrick Annan
    Mbilia, Henry
    Owusu, Ebenezer
    Adjei-Anang, Joseph
    [J]. OPHTHALMIC EPIDEMIOLOGY, 2022, 29 (04) : 374 - 383
  • [6] Prevalence and Incidence of Dry Eye Disease in Asia: A Systematic Review and Meta-Analysis
    Cai, Youran
    Wei, Jintao
    Zhou, Jiaxin
    Zou, Wenjin
    [J]. OPHTHALMIC RESEARCH, 2022, 65 (06) : 647 - 658
  • [7] Effect of Intense Pulsed Light Therapy in Dry Eye Disease Caused by Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
    Miao, Sen
    Yan, Ran
    Jia, Yusong
    Pan, Zhiqiang
    [J]. EYE & CONTACT LENS-SCIENCE AND CLINICAL PRACTICE, 2022, 48 (10): : 424 - 429
  • [8] Dyslipidemia Exacerbates Meibomian Gland Dysfunction: A Systematic Review and Meta-Analysis
    Tomioka, Yasufumi
    Kitazawa, Koji
    Yamashita, Yohei
    Numa, Kohsaku
    Inomata, Takenori
    Hughes, Jun-Wei B.
    Soda, Rina
    Nakamura, Masahiro
    Suzuki, Tomo
    Yokoi, Norihiko
    Sotozono, Chie
    [J]. JOURNAL OF CLINICAL MEDICINE, 2023, 12 (06)
  • [9] Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin
    Tao, Tianchang
    Tao, Liming
    [J]. EYE, 2020, 34 (10) : 1797 - 1808
  • [10] Systematic review and meta-analysis of treating meibomian gland dysfunction with azithromycin
    Tianchang Tao
    Liming Tao
    [J]. Eye, 2020, 34 : 1797 - 1808